Eunnies Events Management

  Again I had a very wonderful day attending DOST ITDI  MMIC WEBCAST today March 31 2021 which is very informative, very educational and very inspiring wherein they discussed extensively how MMIC help our industry in creating new product out of what we already considered trash. They shared their solid insight ,knowledge and experiences to be able to duplicate themselves and produce people who can clearly catch their advocacy to innovate And produce . As they mentioned Change is dynamic.That is  why in every seasons of change we all have to be  efficient and think of something that can help not just the pesent generations but also the next generations to come remember there is always a way to do  it.. Look around us and see how much resources you have and think of ideas out of the resources that you have...It is not how much you have but it is what you do with what you have to multiply it so that many people can benefit . That mindset is what we need special...

  DOST-ITDI to pivot backend innovation through its webcast @ Innohub sa Pinas The Industrial Technology Development Institute (DOST-ITDI), in its bid to contribute to industrialization and progress through R&D initiatives, will conduct a webcast for its newly opened Modular Multi-Industry Innovation Center (MMIC) or InnoHub sa Pinas on March 31, 2021. Following MMIC’s successful launch in December 2020 and inauguration in February 2021, ITDI once again invites industry partners and stakeholders to share their insights and expectations about the new facility. InnoHub sa Pinas is an industrial processing facility with multifunctional/multi-application modular unit operation equipment that can be retrofitted to accommodate different manufacturing lines. It is built to serve the needs of the food, personal care, and pharma-nutraceutical industries using its three main processing lines for nut/seed and oils, mix blend powders, and liquids/emulsions which rely mainly on by-products ...

Today March 25 2021 is the Amcen MATDEV Stakeholders Forum. Glad to be part of it again invited by Ms.Adelia of DOST ITDI . I always love to attend event of DOST ...My very first one is from DOST Pagasa where we had a 2 nights and 3 days stay in a hotel in Cavite  then invitation from DOST ITDI a virtual Inauguration event then this one Amcen is a known as a shared facility between ITDI and the Metals Industry Research and Development Center (DoST-MIRDC). And The second facility inside Amcen is MIRDC's RAPPID-ADMATEC (Research on Advanced Prototyping for Product Innovation and Development using Additive Manufacturing Technologies They  always targets  to reduce cost of the raw materials by using local resources and make sure to increase effective use of AMabled products. MATDEV means Materials Development wherein they innovate to help our economy specially in this pandemic time these is very much needed right now .We need to always advance And make sure we ...

  The  Industrial Technology Development Institute (DOST-ITDI)  is gathering  industry, academe, government, and non-profit organizations  in a stakeholders' forum to be held on  March 25, 2021 , via the Zoom Meeting platform, to present  MATDEV Laboratory’s current and future activities on additive manufacturing (AM). AM  is the technique being used by the MATDEV Laboratory  to produce models and prototypes  directly from  three-dimensional (3D) computer-aided design (CAD)  without using any tools or fixtures. Funded by the  DOST Grants-In-Aid Program ,  MATDEV Laboratory  is a project under the  Advanced Additive Manufacturing R&D Program. Inaugurated on December 22, 2020, the MATDEV Laboratory undertakes  research and development  on  materials for use in additive manufactured products  to reduce the cost of raw materials by using local resources. However, AM has been in use  ...

 Press Release: Sputnik V receives FDA’s Emergency Use Authorizati The Philippine Food and Drug Administration (FDA) has granted emergency use authorization (EUA) to Sputnik V, one of Russia’s COVID-19 vaccines, today, 19 March 2021, as announced by FDA Director General Eric Domingo during the Department of Health (DOH)’s Special Briefing. Authorized for limited use among Filipino individuals aged 18 and above, the non-replicating viral vector COVID-19 vaccine was developed by the Gamaleya Research Institute of Epidemiology and Microbiology through the support of the Russian Direct Investment Fund (RDIF). Both Gamaleya and RDIF were identified by the Department of Science and Technology (DOST), which chairs the Task Group on Vaccine Evaluation and Selection (TG VES), as one of its bilateral partners for the possible conduct of vaccine clinical trials in the Philippines. The DOST-convened Vaccine Expert Panel (VEP) has reviewed the initial clinical trial data of Sputnik V, which ser...